Neutral
Globe Life (GL) is experiencing investor optimism ahead of its second-quarter earnings, with expectations of double-digit profit growth. While one val...
Neutral
Globe Life Inc. navigates the competitive US life and supplemental health insurance market by focusing on disciplined underwriting, cost control, and ...
Bullish
Globe Life Inc. operates as a U.S.-based life and health insurer, focusing on individual policies and a long-term strategy built on stable underwritin...
Neutral
Globe Life Inc. (US37959E1029) is a NYSE-listed insurer focusing on individual life and supplemental health coverage. The company's business model emp...
Neutral
Dolores L. Skarjune, Executive Vice President of Globe Life Inc. (NYSE:GL), sold 1,850 shares of company stock for $331,483 after exercising employee ...
Neutral
GLOBE LIFE INC. EVP Dolores L. Skarjune exercised employee stock options for 1,850 shares at $103.23 per share and subsequently sold all 1,850 shares ...
Globe Life has amended and restated its revolving credit facility and term loan, appointing Wells Fargo Bank as Administrative Agent for both. The rev...
Globe Life Inc. (NYSE: GL) has entered into new credit agreements, extending the maturity dates for its revolving credit facility to June 26, 2031, an...
Neutral
This article provides financial data for Globe Life Inc. (TMJ) on the Dusseldorf Stock Exchange, specifically focusing on its price-to-earnings forwar...
Neutral
Cheryl Alston, a director at Globe Life Inc. (NASDAQ:GL), sold approximately $1.48 million worth of company common stock after exercising options to a...
A recent SEC filing indicates that an insider at Globe Life Inc. sold shares valued at $1,480,134. This transaction follows several other insider shar...
Bullish
TD Cowen has designated Globe Life as its top pick in the life insurance sector, raising its price target to $215, citing a strong fundamental outlook...
Bullish
TD Cowen analyst Andrew Kligerman maintained a 'Buy' rating for Globe Life (GL) and increased the price target to $215.00 from $199.00, indicating an ...
Neutral
TD Cowen has increased its price target for Globe Life (NYSE:GL) to $215 from $199, maintaining a Buy rating and designating it as a top pick in U.S. ...
Neutral
This article from Investing.com reports on a Form 4 filing for Globe Life Inc. dated June 22nd. The brief piece includes the stock symbol GL and its c...
Rebecca E. Zorn, EVP & Chief Talent Officer at Globe Life Inc. (NYSE: GL), exercised 2,000 employee stock options at $98.32 per share and subsequently...
Neutral
This article provides an in-depth look at Globe Life stock, focusing on its business model, valuation, and current analyst sentiment. It highlights th...
Bullish
This article provides background information on Globe Life (US37959E1029), a US life and health insurer and S&P 500 constituent, as there are no new h...
Zacks Investment Research recently upgraded Globe Life (GL) to a "Buy" rating due to more optimistic analyst earnings estimates. This upgrade is suppo...
Neutral
This article provides a Friday review of Globe Life (US37959E1029) stock, noting a quiet news week for the insurer. Investors are directed to focus on...